Healthbox continues to support entrepreneurial innovation through the Healthbox Studio program and the Intermountain Healthcare Innovation Fund. Read below to learn more.
Chicago Studio Program
Healthbox Chicago Studio Program | October 9-13, 2017
Healthbox continues to support entrepreneurial innovation through the annual flagship Chicago Studio. The Healthbox Chicago Studio is a five-day program dedicated to advancing innovative digital health solutions through peer-to-peer collaboration, speaker sessions, and cultivating meaningful relationships with senior healthcare leaders, investors, and industry partners. Ten early stage startups are selected from an international pool of applicants to participate. This unique program is free of charge to all participating companies with no required equity exchange. Read more »
Applications are now open for the 2017 program.
Apply by Friday, July 21 for consideration.
Intermountain Healthcare Innovation Fund
As part of our relationship with Intermountain Healthcare — a not-for-profit health system based in Salt Lake City, Utah — Healthbox is the general partner of the $35M Intermountain Healthcare Innovation Fund. The Fund’s mission is to source, evaluate, and invest in innovative companies that represent a high return, high growth opportunity and that align with Intermountain's mission of helping people live the healthiest lives possible. The Fund invests in healthcare IT companies with a strong provider angle. The Fund is managed by Caroline Arenz, Leland Brewster, Dr. Eric Louie, Neil Patel, and Jeffrey Ries.
The Fund invests in healthcare IT companies with a strong provider angle that meet the following criteria:
Investment Size: Minimum investment of $1 million with a target of $3-5 million invested over the life of a portfolio company.
Company Stage: Majority of investments will fall within Series A – C, but the fund is stage agnostic.
Investment Scope: Capital efficient healthcare IT and services companies; pre-approval therapeutics, devices, and diagnostics will generally be considered out of scope; limited consideration may be given to FDA approved, or otherwise low regulatory risk, devices and diagnostics.
Our Work to Date:
Early-State Companies Evaluated
Healthbox Program Alumni
Investments Made to Date